Stimulant ADHD medication and risk for substance abuse

Chang, Zheng, Lichtenstein, Paul, Halldner, Linda, D'Onofrio, Brian, Serlachius, Eva, Fazel, Seena, Långström, Niklas, Larsson, Henrik·2014·Journal of Child Psychology and Psychiatry
DOI 10.1111/jcpp.12164

Cited by (222)

Items 101–200 of 222

  1. ADHS bei erwachsenen Patienten mit Substanzkonsumstörungen
    Mathias Luderer, Falk Kiefer, Andreas Reif, Franz Moggi · 2019 · Der Nervenarzt
  2. Common and distinct neural connectivity in attention‐deficit/hyperactivity disorder and alcohol use disorder studied using resting‐state functional magnetic resonance imaging
    Àlvar Farré‐Colomés, Sarah Gerhardt, Mathias Luderer, Esther Sobanski, Falk Kiefer, Sabine Vollstädt‐Klein · 2021 · Alcoholism Clinical and Experimental Research
  3. Support for primary care prescribing for adult ADHD in England: national survey
    Anna Price, Kieran Becker, John H Ward, Obioha Chukwunyere Ukoumunne, Rebecca Gudka, Anita Salimi, Faraz Mughal, G. J. Meléndez‐Torres, Jane Rebecca Smith, Tamsin Newlove‐Delgado · 2024 · British Journal of General Practice
  4. Aufmerksamkeitsdefizit‑/Hyperaktivitätsstörung im Kindes- und Jugendalter
    Alexander Häge, Sarah Hohmann, Sabina Millenet, Tobias Banaschewski · 2020 · Der Nervenarzt
  5. Methylphenidate for ADHD
    Mina S. Fazel · 2015 · BMJ
  6. Onset and Severity of Early Disruptive Behavioral Disorders in Treatment-Seeking Substance Use Disorder Patients with and without Attention-Deficit/Hyperactivity Disorder
    Rafael A González, M. Vélez-Pastrana, M. Blankers, Amanda Bäcker, M. Konstenius, M. Holtmann, F. Levin, Moritz Noack, S. Kaye, Z. Demetrovics et al. · 2020 · European Addiction Research
  7. Prescription stimulant use during long-term opioid therapy and risk for opioid use disorder
    Jeffrey F. Scherrer, Joanne Salas, R. Grucza, T. Wilens, Patrick D. Quinn, Mark D. Sullivan, R. Rossom, Eric A. Wright, B. Piper, Katherine Sanchez et al. · 2022 · Drug and Alcohol Dependence Reports
  8. An updated safety review of the current drugs for managing ADHD in children
    Erika Ryst, Ann Catherine Childress · 2023 · Expert Opinion on Drug Safety
  9. The need for alternative treatments for attention-deficit/hyperactivity disorder
    Klaus W. Lange · 2020 · University of Regensburg Publication Server (University of Regensburg)
  10. Long-term changes on behavioral addictions symptoms among adults with attention deficit hyperactivity disorder treated with methylphenidate
    Giacomo Grassi, Corinna Moradei, Chiara Cecchelli · 2024 · Journal of Behavioral Addictions
  11. Frequent Pain is Common Among 10-11-Year-Old Children with Symptoms of Attention Deficit Hyperactivity Disorder
    Sara Berggren, Stefan Bergman, Gerd Almquist‐Tangen, Jovanna Dahlgren, Josefine Roswall, Julia S. Malmborg · 2024 · Journal of Pain Research
  12. Prevalence of pharmacotherapy for attention‐deficit/hyperactivity disorder and prescription stimulant misuse: A national study of US college students
    Alynna G. Summit, Madison C. Moseley, Natasha Chaku, Kit K. Elam, Wura Jacobs, Alyssa M. Lederer, Ellen L. Vaughan, Patrick D. Quinn · 2024 · Addiction
  13. Role of education settings in transition from child to adult health services for young people with ADHD
    Simon Benham‐Clarke, Tamsin Jane Ford, Siobhan B. Mitchell, Anna Price, Tamsin Newlove‐Delgado, Sharon Blake, Helen Eke, Darren A. Moore, Abigail Emma Russell, Astrid I.W.A. Janssens · 2021 · Emotional and Behavioural Difficulties
  14. Trajectories of Binge Drinking Behavior across Adolescence among Juvenile Offenders and the Role of ADHD for Predicting Development
    Thomas Walter Wojciechowski · 2017 · Deviant Behavior
  15. Attention-Deficit/Hyperactivity Disorder in Medicaid-Enrolled Autistic Adults
    Benjamin E. Yerys, Sha Tao, Lindsay Shea, Gregory L. Wallace · 2025 · JAMA Network Open
  16. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
    Ole Jakob Storebø, Maja Rosenberg Overby Storm, Johanne Pereira Ribeiro, Maria Skoog, Camilla Groth, Henriette Edemann-Callesen, Julie Perrine Schaug, Pernille Juul Darling, Christel-Mie Lykke Huus, Morris Zwi et al. · 2025 · Cochrane Database of Systematic Reviews
  17. Long-term medication for ADHD (LMA) trial: 2-year prospective observational study in children and adolescents. Core symptoms, daily functioning, and comorbidity outcomes
    Mats Johnson, Jakob Åsberg Johnels, S. Östlund, Kristina Jakobsson, Jenny Högstedt, P. Javid Larsson, Christopher Gillberg, Eva Billstedt · 2024 · European Archives of Psychiatry and Clinical Neuroscience
  18. Development of an innovative adult attention-deficit hyperactivity disorder clinic
    Kelly C. Lee, Estelle Kim, Jaye Kim · 2020 · Mental Health Clinician
  19. Attention-deficit/hyperactivity disorder is associated with more alcohol problems and less substance-free reinforcement: A behavioral economics daily diary study of college student drinkers.
    Lauren E. Oddo, Keanan J. Joyner, James G. Murphy, Samuel F. Acuff, Nicholas P. Marsh, Amanda Steinberg, Andrea M. Chronis-Tuscano · 2024 · Psychology of Addictive Behaviors
  20. Sex Difference in Attention-Deficit/Hyperactivity Disorder Contributes to the Sex Difference in Crime and Antisocial Behavior
    Robert F. Eme · 2015 · Violence and Gender
  21. Attention deficit/Hyperactivity disorder
    Kevin M. Antshel, Haley McBride · 2023 · Elsevier eBooks
  22. Attention deficit hyperactivity disorder, physical abuse and methylphenidate treatment in children
    Kenneth K. C. Man, Le Gao, Wallis C. Y. Lau, Min Fan, David Coghill, Esther W. Chan, Celine Sze Ling Chui, Xue Li, Adrienne Y L Chan, Terry Y S Lum et al. · 2023 · Nature Mental Health
  23. Attention deficit hyperactivity disorder in adults
    Mark Ellett Pitts · 2014 · Nurse Prescribing
  24. Medikamentöse Therapie der Aufmerksamkeitsdefizit‑/Hyperaktivitätsstörung im Erwachsenenalter
    Wolfgang Retz, Petra Retz‐Junginger, Sergiy Davydenko, Michael Rösler · 2020 · Der Nervenarzt
  25. Characteristics and outcomes of cases with methylphenidate abuse, dependence or withdrawal: an analysis of spontaneous reports in EudraVigilance
    Lara T. Hartmayer, Falk Hoffmann, Christian Bachmann, Kathrin Jobski · 2023 · International Clinical Psychopharmacology
  26. The Association Between Suspected Long–COVID and Stimulant Prescribing in the United States
    R. Koonce, Bradley C. Martin · 2023 · Psychiatry Research
  27. Preventing the Next Epidemic: Prescribed Stimulant Abuse
    Kamala D. Via · 2019 · The Journal for Nurse Practitioners
  28. Attention-deficit/hyperactivity disorder combined subtype exacerbates opioid use disorder consequences: Mediation by impulsive phenotypes
    Liam Browning, Ciara N. Cannoy, Tabitha E.H. Moses, Leslie H. Lundahl, David M. Ledgerwood, Mark K. Greenwald · 2024 · Drug and Alcohol Dependence
  29. OROS-methylphenidate to reduce ADHD symptoms in male prisoners aged 16–25 years: a RCT
    Philip J. Asherson, Lena Johansson, Rachel Holland, Megan Bedding, Andrew Forrester, Laura Giannulli, Ylva Ginsberg, Sheila Howitt, Imogen Kretzschmar, Stephen M. Lawrie et al. · 2022 · Efficacy and Mechanism Evaluation
  30. Concomitant Drug Use among Opioid-Dependent Patients with and without Attention Deficit Hyperactivity Disorder: Does Methylphenidate Merit a Trial?
    Letizia Tschudi, Sebastian Karl Maximilian Fischer, Evgeniy Perlov, Markus R. Baumgartner, Michael Soyka, Thomas Müller, Erich Seifritz, Jochen Mutschler · 2023 · European Addiction Research
  31. Food intolerance and the few-foods (or oligoantigenic) diet in children with attention-deficit hyperactivity disorder
    Klaus W. Lange, Andreas Reißmann, Yukiko Nakamura, Katharina M. Lange · 2023 · Food Science and Human Wellness
  32. Preference for Immediate Rewards in Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder: A Shared Intermediate Phenotype?
    Anouk Scheres, Martina Balan, Maria D. Paraskevopoulou, Arnt Schellekens · 2024 · Current Addiction Reports
  33. Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung und suizidales Verhalten
    Anna Anschlag, Alisa Susann Cosan, Katja Becker, Daria Kasperzack · 2025 · Die Psychotherapie
  34. Konzeptualisierung der Psychotherapie bei ADHS und Sucht
    Samira Groß, Alexandra Philipsen · 2015 · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice
  35. Managing Adult Attention-Deficit/Hyperactivity Disorder With Comorbid Substance Use Disorder
    Ward, Burton, Bahji, Anees, Crockford, David · 2022 · Canadian Journal of Addiction
  36. Pharmacotherapy of ADHD in Adults
    Michael Rösler, Wolfgang Retz, Daniel Turner · 2022 · Springer eBooks
  37. Attention Deficit/Hyperactivity Disorder in Adults : Prevalence, Psychiatric Comorbidities and Long-term Outcome
    Dan Edvinsson · 2017 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  38. Wider health needs in attention deficit hyperactivity disorder from lived and professional experience: a qualitative framework analysis
    John Ward, Audrey McBride, Rebecca Gudka, Kieran Becker, Tamsin Newlove‐Delgado, Anna Price · 2024 · BMJ Open
  39. Serotonin-dopamine interactions in psychostimulant-induced gene regulation: SSRI antidepressants potentiate gene regulation by methylphenidate (Ritalin) in the striatum and enhance behavioral profile indicative of addiction liability in rodents
    Heinz Steiner, Michael Hrabak, Carlos A. Bolaños‐Guzmán · 2025 · Neuroscience & Biobehavioral Reviews
  40. Exploring the Escalating Trends and Variances in Attention Deficit Hyperactivity Disorder Prevalence: A Critical Review
    Taha Hussain, Prashant Neupane, Vineet Khunger · 2025 · Cureus
  41. Methylphenidate and Its Impact on Redox Balance and Behavior
    George Jîtcă, Ingrid Evelin Mehelean, Ana Natalia Maier, Carmen-Maria Rusz · 2025 · Journal of Xenobiotics
  42. Connecting the dots and finding the way forward: Pharmacological, neuromodulatory, and psychotherapeutic interventions for the complex treatment of adult ADHD
    Xénia Gonda, Péter Döme, Lívia Balogh, Máté Baradits, János Réthelyi · 2026 · Pharmacology & Therapeutics
  43. Tout ce que vous devez connaître sur le méthylphénidate (sans oser le demander…)
    Luc Zimmer, Pierre Fourneret · 2018 · Archives de Pédiatrie
  44. Outcomes of untreated attention deficit hyperactivity disorder and the mental health nurse
    Tom Nicholson · 2018 · British Journal of Mental Health Nursing
  45. Classifying Young Children with Attention-Deficit/Hyperactivity Disorder Based on Child, Parent, and Family Characteristics: A Cross-Validation Study
    Evelyn C. Law, Georgios D. Sideridis, Ghadah S. Alkhadim, Jenna Snyder, Margaret A. Sheridan · 2022 · International Journal of Environmental Research and Public Health
  46. Is prevention of ADHD and comorbid conditions in adolescents possible?
    Benedetto Vitiello, Chiara Davico, Manfred Döpfner · 2023 · Journal of Attention Disorders
  47. Practice Pearls for Stimulant Treatment of Attention-Deficit/Hyperactivity Disorder in Youth.
    Danielle L. Stutzman, Julie Ann Dopheide · 2024 · PubMed Central
  48. Caregivers’ Perspectives Regarding the Use of Psychotropic Medication in Children and Young Adults: A Systematic Review
    Phoebe M. Downey, Jack Charles Collins, Sarira El‐Den, Claire Louise O’Reilly · 2025 · International Journal of Social Psychiatry
  49. Aufmerksamkeitsdefizit-/Hyperaktivitätsstörungen – Risiko für Delinquenz im Jugend- und Erwachsenenalter?
    M. Just, A. Kaiser, W. Retz, M. Rösler, T. Banaschewski, Sarah Hohmann, Sabina Millenet · 2017 · Forensische Psychiatrie Psychologie Kriminologie
  50. METHYLPHENIDATE AND CRIME REDUCTION
    Birger Antholz · 2019 · International Journal of Social Sciences
  51. Consumption of Synthetic Cannabinoids in Adult Attention-Deficit/Hyperactivity Disorder: a Pilot Study
    Alexandra Philomena Lam, Sebastian Moeller, Christine Speitling, Martin C. Lam, Alexandra Philipsen, Helge Müller · 2020 · International Journal of Mental Health and Addiction
  52. Adderall-Induced Persistent Psychotic Disorder Managed With Long-Acting Injectable Haloperidol Decanoate
    Saral R. Desai, Erika L Santos, Anca E Toma · 2022 · Cureus
  53. Adult ADHD: Future Directions for Practice and Research
    Stefano Pallanti, Luana Salerno · 2020 · Springer eBooks
  54. Therapeutic Use of Dopamine Enhancers (Stimulants)
    Alessandro Zuddas, Sara Carucci · 2023 · Springer eBooks
  55. Stanowisko grupy badawczej Female ADHD Research Group i Sekcji Kształcenia Specjalizacyjnego PTP dotyczące kontrowersyjnych doniesień medialnych na temat ADHD u osób dorosłych
    Tomasz Maciej Gondek, Agata Todzia-Kornaś, Anna Szczegielniak · 2023 · Psychiatria Spersonalizowana
  56. Diagnosis and Management of Comorbid ADHD in Patients with Substance Use Disorders
    Betsy Busch · 2024 · Springer eBooks
  57. Risk Factors for Adverse Cardiac Events in Individuals Prescribed Stimulants Across the Lifespan
    Destin Groff, Wen‐Jan Tuan, Kraig Holt, James R. Latronica, Curtis Bone · 2025 · Journal of Attention Disorders
  58. Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review
    Daeun Jung · 2026 · Annals of Child Neurology
  59. Treatment Resistance in Attention-Deficit/Hyperactivity Disorder
    Amber D. Hunt, David W. Dunn, Hillary S. Blake, Jennifer Downs · 2018 · Springer eBooks
  60. ADHD Symptom Malingering and Nonmedical Drug Use in Adults
    Sujith Ramachandran, Jeffrey Michael Pavlacic, John N. Young, John P. Bentley · 2023 · Autism and child psychopathology series
  61. The socioeconomic burden of adult attention-deficit/hyperactivity disorder in Spain
    María Merino, Paulina Maravilla‐Herrera, Teresa Martín Lorenzo, Juan Antonio Arance, Julio Bobes, Montse Corrales F, Fátima Guzmán, María del Carmen Morales, Carlos Mur · 2024 · Global & Regional Health Technology Assessment
  62. Disorders due to Substance Use: Stimulants
    Kevin A. Sevarino, Michael Farrell · 2024 · Springer eBooks
  63. ADHD Presentation and Alcohol Use Among Juvenile Offenders: A Group-Based Trajectory Modeling Approach
    Thomas Walter Wojciechowski · 2017 · Journal of Child & Adolescent Substance Abuse
  64. Medikamentöse Therapie der ADHS bei Erwachsenen
    Michael Rösler, Wolfgang Retz · 2020 · PSYCH up2date
  65. Management and treatment of attention-deficit/hyperactivity disorder
    Alessandro Zuddas, Sara Carucci · 2020
  66. Adult ADHD in Psychiatric Conditions
    Stefano Pallanti, Luana Salerno · 2020 · Springer eBooks
  67. Pharmacotherapy of ADHD in Adults
    Michael Rösler, Wolfgang Retz, Daniel Turner · 2021 · Springer eBooks
  68. Comorbid Psychiatric Disorders and Related Sociodemographic Factors in Adolescents with Attention-Deficit Hyperactivity Disorder
    Serdar Karatoprak, Yunus Emre Dönmez · 2022 · Journal of Dr Behcet Uz Children s Hospital
  69. A Pediatric Patient with Severe Obstructive Sleep Apnea and Comorbid Depression and Substance Abuse
    Caitlin E. Leconte, Joshua W. Ng, Ann M. Manzardo, Mitchell M. Douglass · 2023 · Case Reports in Psychiatry
  70. Neurocognitive deficits in adult ADHD : preclinical and clinical studies
    Anneka Tomlinson · 2014 · Research Explorer (The University of Manchester)
  71. When ADHD and substance use disorders coexist : etiology and pharmacological treatment
    Charlotte Borg Skoglund · 2015 · Figshare
  72. The comorbidity between attention-deficit/hyperactivity disorder and other neurodevelopmental disorders : aetiology, treatment and outcomes
    Laura Ghirardi · 2019 · Figshare
  73. Recent Progress in Psychosocial and Psychopharmacologic Treatments for ADHD
    Jeffrey H. Newcorn, Iliyan Ivanov, Anil Chacko · 2015 · Current Treatment Options in Psychiatry
  74. The Effects of Long-Term Use of Stimulant Medication for Attention Deficit Hyperactivity Disorder
    Melissa M. Jones · 2015
  75. ADHD and Risky Substance Use in Male Adolescents
    Robert F. Eme · 2018 · Child and Adolescent Psychopharmacology News
  76. Attention-defi cit hyperactivity disorder 2 Adult attention-defi cit hyperactivity disorder: key conceptual issues
    Philip J. Asherson, Jan K. Buitelaar, Stephen V. Faraone, K G Jebsen, Luís Augusto Rohde · 2016
  77. Managing Adult Attention-Deficit/Hyperactivity Disorder: To Treat or Not To Treat?
    Swapna Deshpande, Britta Klara Ostermeyer, Akshay P. Lokhande, Humaira Abid, Asim A. Shah · 2017 · Psychiatric Annals
  78. Child Use of Controlled Substances for Treating Attention Deficit Disorder
    Cheyenne Goodspeed · 2015 · UC Merced Undergraduate Research Journal
  79. Conhecimentos e Lacunas dos Professores do 1. º Ciclo acerca da PHDA
    Luís Oliveira, Marcelino Arménio Martins Pereira, Ana María Serrano, Teresa Medeiros · 2017 · Revista de Estudios e Investigación en Psicología y Educación
  80. Neuromodulation in Attention-Deficit/Hyperactivity Disorder: Toward a Precision Psychiatry Approach
    Luana Salerno, Sonia Gaur, Giacomo Grassi, Stefano Pallanti · 2020 · Springer eBooks
  81. La doppia diagnosi ADHD e SUD
    Gianmaria Zita, Giovanni Migliarese · 2020 · MISSION
  82. Attention-deficit/hyperactivity disorder and adverse health outcomes : from association to prevention
    Shihua Sun · 2020 · Figshare
  83. Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Kindern und Jugendlichen
    Thomas Jans, Alexander Häge, Sarah Hohmann, Marcel Romanos, Tobias Banaschewski · 2021 · Kinder- und Jugendmedizin
  84. Psychiatric Drug Prescription and Temporal Associations with a First Diagnosis of Gambling Disorder—Results from a National Register Study
    Carolina Widinghoff, Jonas Berge, A. Håkansson · 2021 · International Journal of Mental Health and Addiction
  85. ADHD and Risky Substance Use in Male Adolescents
    Robert F. Eme · 2017 · Child and Adolescent Psychopharmacology News
  86. Behandlung von riskantem, schädlichem und abhängigem Alkoholgebrauch
    Falk Kiefer, Sabine Hoffmann, Julia Arens, Martin Beutel, Oliver Bilke-Hentsch, Gallus Bischof, Udo Bonnet, Jan Malte Bumb, Ralf Demmel, Silke Diestelkamp et al. · 2022 · Springer eBooks
  87. Aufmerksamkeitsdefizit-/Hyperaktivitäts-Syndrom
    Mark Brotzmann · 2023 · Springer eBooks
  88. Avaliação da eficácia do aplicativo FOCUS TDAH no monitoramento de adultos com Transtorno de Déficit de Atenção/Hiperatividade
    Luiz Roberto Bumbles de Abreu Carvalho · 2023 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  89. Psychostimulanzien und andere Arzneistoffe, die zur Behandlung der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) angewendet werden
    Susanne Walitza, Lukasz Smigielski, Manfred Gerlach · 2023 · Springer eBooks
  90. Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung
    Susanne Walitza, Tobias Banaschewski, Alexander Häge · 2023 · Springer eBooks
  91. Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) im Kindes- und Jugendalter
    Manfred Döpfner, Tobias Banaschewski · 2022 · Springer Reference Medizin
  92. Disorders Due to Substance Use: Stimulants
    Kevin A. Sevarino, Michael Farrell · 2023 · Springer eBooks
  93. Impact of Treatment with Central Nervous System Stimulant and Risk of Substance Use Disorder in Adults with Attention-Deficit/Hyperactivity Disorder
    Ki Jin Jeun, Mohammad Abdullah Al-Mamun · 2024 · International Journal of Mental Health and Addiction
  94. Chapter 64. Treatment of Attention-Deficit/Hyperactivity Disorder in Adults
    Elizabeth Deckler, Barbara J. Coffey · 2024 · American Psychiatric Association Publishing eBooks
  95. Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) im Kindes- und Jugendalter
    Manfred Döpfner, Tobias Banaschewski · 2024 · Springer Reference Medizin
  96. Therapeutic Use of Dopamine Enhancers (Stimulants)
    Alessandro Zuddas, Sara Carucci · 2024 · Springer eBooks
  97. Risques du méthylphénidate au long cours
    Lucie Jurek, Samuele Cortese, Mikaïl Nourredine · 2024 · Annales Médico-psychologiques revue psychiatrique
  98. Cardiac Dysfunction in Patients with Alcohol Use Disorder and Comorbid Adult Attention-Deficit Hyperactivity Disorder: A 2D Echocardiography Study
    Mrudula Kambhampati, Kaviraja Udupa, Arun Kandasamy, R. Govindaraj, Parthipulli Vasuki Prathyusha, Apoorva Balakrishna, Sangeetha Kalappa, Talakad Narasappa Sathyaprabha · 2024 · SN Comprehensive Clinical Medicine
  99. Stimulanzien
    Gerhard Gründer · 2024 · Elsevier eBooks
  100. Relationship of Amphetamines in Reducing Substance Abuse Risks Among ADHD Patients
    Ashley Deng, Eduardo D Espiridion · 2024 · Transformative Medicine